1Feday J, Shin HR, Bray F, et aL Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2/)08 [J]. Int J Cancer, 2010, 127(12) : 2893-2917.
2Yoo CH, Nob. SH, Shin DW, et al. Recurrence following curative resection for gastric carcinoma[J]. Br J Surg, 20130, 87(2) : 236-242.
3Schwarz RE, Zagala-Nevarez K. Recurrence patterns after radical gastrectomy for gastric cancer: prognostic factors and implications for postoperative adjuvant therapy[J]. Ann Surg Oncol, 2002,9(4) :394-400.
4Saito H, Kihara K, Kuroda H, et al. Surgical outcomes for gastric cancer patients with intraperitoneal free cancer cell, but no macroscopic peritoneal metastasis[J]. J Surg Oncol, 2011,104(5) :534-537.
5Glehen O, Gilly FN, Boutitie F, et al. Toward curative treatment of peritoneal careinomatosis from nonovarian origin by cytoreduetive surgery combined with perioperative intraperitoneal chemotherapy: a muhi-institutional study of 1,290 patients[J].Cancer, 2010,116(24) :5608-5618.
6Ceelen WP, Pahlman L, Mahteme H. Pharmacodynamic aspects of intraperitoneal cytotoxic therapy[J]. Cancer Treat Res, 2007, 134:195-214.
7Cavaliere R, Ciocatto EC, Giovanella BC, et al. Selective heat sensitivity of cancer cells. Biochemical and clinical studies[J]. Cancer, 1967,20(9) :1351-1381.
8Yang XJ, Huang CQ, Suo T, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase 11I randomized clinical trial[J]. Ann Surg Oncol, 2011, 18(6) : 1575 1581.
9Rudloff U, Langan RC, Mullinax JE, et al. Impact of maximal cyt6reductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: Results of the GYMSSA trial[J]. J Surg Oncol, 2014, 110 (3) :275-284.
10Elias D, Lefevre JH, Chevalier J, et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin[J]. J Clin Oncol, 2009,27(5) :681-685.
